Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Epilepsy

  Free Subscription


Articles published in Brain Dev

Retrieve available abstracts of 37 articles:
HTML format



Single Articles


    August 2025
  1. CHEN J, Zheng T, Liu J
    Unpacking the genetic landscape of epilepsy: key considerations for future research and clinical translation.
    Brain Dev. 2025;47:104429.
    PubMed    


  2. APHALE P, Dokania S, Shekhar H
    Letter to the editor: Immune dysregulation in new-onset refractory status epilepticus (NORSE): current insights and therapeutic perspectives.
    Brain Dev. 2025;47:104422.
    PubMed    


  3. ESER M, Hekimoglu G, Kutlubay B
    Epilepsy as a multifaceted neurological disease: insights from a genetic study of novel gene variants.
    Brain Dev. 2025;47:104418.
    PubMed     Abstract available


    July 2025
  4. HANIN A, Hirsch LJ
    Immune dysregulation in new-onset refractory status epilepticus (NORSE): current insights and therapeutic perspectives.
    Brain Dev. 2025;47:104406.
    PubMed     Abstract available


  5. KANEMURA H
    Association between epilepsy and attention deficit/hyperactivity disorder - correlation between interictal epileptiform discharges and behavioral disturbances.
    Brain Dev. 2025;47:104403.
    PubMed     Abstract available


  6. WATANABE S, Enokizono T, Nishimura M, Maruo K, et al
    Valproate and lamotrigine combination therapy in children with drug-resistant focal epilepsy: an observational analysis focusing on neuroimaging abnormalities.
    Brain Dev. 2025;47:104395.
    PubMed     Abstract available


  7. TAKEUCHI H, Kikuchi K, Takeda R, Hirata Y, et al
    Characteristics of withdrawal seizures in children with refractory status epilepticus who responded favorably to continuous midazolam therapy.
    Brain Dev. 2025;47:104394.
    PubMed     Abstract available


    June 2025
  8. CAMPANARIO DA SILVA PEREIRA C, Gomes Dantas FD, da Rosa Baratela WA, Antunes da Costa F, et al
    Tuberous sclerosis complex: Clinical, genetic and 7T-MRI neuroimaging findings.
    Brain Dev. 2025;47:104386.
    PubMed     Abstract available


  9. YUN HJ, Kim SY, Kim W, Lee S, et al
    Epilepsy phenotypes and responses to antiseizure medications in pediatric patients with EEF1A2-related epilepsy.
    Brain Dev. 2025;47:104382.
    PubMed     Abstract available


  10. CARABALLO RH, Fortini S, Beltran L, Semprino M, et al
    Focus on epilepsy and epilepsy syndromes in children with autism spectrum disorders: a study of 74 patients.
    Brain Dev. 2025;47:104385.
    PubMed     Abstract available


  11. MORITA S, Yamauchi T, Tamura Y, Suzuki T, et al
    Endocrinological study of low-dose adrenocorticotropic hormone therapy without tapering in infantile epileptic spasms syndrome.
    Brain Dev. 2025;47:104376.
    PubMed     Abstract available


  12. PALANCI O, Kamasak T, Aydin Kasap Z, Eyuboglu I, et al
    Volumetric and microstructural changes in the Hippocampus and cingulum in children with west syndrome.
    Brain Dev. 2025;47:104365.
    PubMed     Abstract available


    May 2025
  13. SAENCHAI W, Manopunya S, Kosarat S, Khuwuthyakorn V, et al
    Drug-resistant epilepsy in children post-neonatal seizures: Clinical profiles and predictors.
    Brain Dev. 2025;47:104373.
    PubMed     Abstract available


    April 2025
  14. YANG Y, Kang J, Zhang Y, Cai Y, et al
    Diagnostic value of serum miRNA-134-3p and miRNA-155-5p for monitoring seizure control in pediatric epilepsy.
    Brain Dev. 2025;47:104357.
    PubMed     Abstract available


    March 2025
  15. ITO S, Nishikawa A, Kuroiwa R, Honda K, et al
    COVID-19 infection and vaccination in children with Dravet syndrome or infantile epileptic spasms syndrome: An internet survey in Japan.
    Brain Dev. 2025;47:104352.
    PubMed     Abstract available


    February 2025
  16. TEKIN HG, Edem P
    Video game exposure in children with epilepsy: EEG and clinical findings.
    Brain Dev. 2025;47:104329.
    PubMed     Abstract available


    January 2025
  17. KOBAYASHI K, Shibata T, Tsuchiya H, Akiyama M, et al
    Hypotheses of pathophysiological mechanisms in epileptic encephalopathies: A review.
    Brain Dev. 2025;47:104318.
    PubMed     Abstract available


  18. SHIM Y, Kim H, Chae JH, Kim KJ, et al
    Analysis of initial seizure characteristics in patients with infantile onset genetic epilepsy.
    Brain Dev. 2025;47:104319.
    PubMed     Abstract available


    December 2024
  19. TAKEUCHI H, Kikuchi K, Takeda R, Hirata Y, et al
    Quantitative analysis of (123)I-iomazenil single-photon emission computed tomography findings from patients with infantile epileptic spasm syndrome.
    Brain Dev. 2024;47:104314.
    PubMed     Abstract available


  20. KIKUCHI K, Kuki I, Nishiyama M, Ueda Y, et al
    Japanese guidelines for treatment of pediatric status epilepticus - 2023.
    Brain Dev. 2024;47:104306.
    PubMed     Abstract available


    November 2024
  21. WENG Y, Rao X, Ma B, Lin X, et al
    Efficacy, safety, and tolerability of adjunctive perampanel in the treatment of pediatric patients aged 4-18 years with epilepsy: A single-center, retrospective, observational real-world study.
    Brain Dev. 2024;47:104305.
    PubMed     Abstract available


  22. TSUCHIYA H, Shibata T, Sasaki T, Akiyama M, et al
    A retrospective study on post-operative recovery of daily living activity after total corpus callosotomy.
    Brain Dev. 2024;46:339-343.
    PubMed     Abstract available


    October 2024
  23. WU H, Huang C, Xiong S
    Gut microbiota as a potential therapeutic target for children with cerebral palsy and epilepsy.
    Brain Dev. 2024 Oct 18:S0387-7604(24)00127.
    PubMed     Abstract available


  24. SHIMOJIMA YAMAMOTO K, Shimomura R, Shoji H, Yamamoto T, et al
    Glass syndrome derived from chromosomal breakage downstream region of SATB2.
    Brain Dev. 2024;46:281-285.
    PubMed     Abstract available


    September 2024
  25. SHIDE-MORIGUCHI Y, Yamamoto N, Kuki I, Sakuma H, et al
    Myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis with super-refractory status epilepticus.
    Brain Dev. 2024 Sep 10:S0387-7604(24)00126.
    PubMed     Abstract available


    July 2024
  26. MITSUMATSU T, Ito Y, Maki Y, Yamamoto H, et al
    Epileptic foci and networks in children with epilepsy after acute encephalopathy with biphasic seizures and late reduced diffusion.
    Brain Dev. 2024 Jul 31:S0387-7604(24)00098.
    PubMed     Abstract available


    April 2024
  27. SILVA S, Rosas M, Guerra B, Munoz M, et al
    Adolescent-onset epilepsy and deterioration associated with CAD deficiency: A case report.
    Brain Dev. 2024 Apr 18:S0387-7604(24)00057.
    PubMed     Abstract available


    March 2024
  28. TAKEUCHI H, Higurashi N, Toga Y
    Prophylactic antiseizure medications for recurrent status epilepticus in nonsyndromic childhood epilepsy.
    Brain Dev. 2024 Mar 21:S0387-7604(24)00043.
    PubMed     Abstract available


  29. YUKSEL MF, Dogulu N, Yildirim M, Kose E, et al
    Metabolic etiologies in children with infantile epileptic spasm syndrome: Experience at a tertiary pediatric neurology center.
    Brain Dev. 2024 Mar 16:S0387-7604(24)00042.
    PubMed     Abstract available


    January 2024
  30. AKIYAMA T, Saigusa D, Inoue T, Tokorodani C, et al
    Exploration of urine metabolic biomarkers for new-onset, untreated pediatric epilepsy: A gas and liquid chromatography mass spectrometry-based metabolomics study.
    Brain Dev. 2024 Jan 2:S0387-7604(23)00209-7. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


    December 2023
  31. NISHIOKA M, Motobayashi M, Fukuyama T, Inaba Y, et al
    Risk factors for post-encephalopathic epilepsy in patients with acute encephalopathy with biphasic seizures and late reduced diffusion.
    Brain Dev. 2023 Dec 18:S0387-7604(23)00194.
    PubMed     Abstract available


  32. DE KNEGT VE, Borresen ML, Knudsen M, Thomsen KM, et al
    Current state of hemispherectomy and callosotomy for pediatric refractory epilepsy in Denmark.
    Brain Dev. 2023 Dec 2:S0387-7604(23)00179-1. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


    November 2023
  33. DILENA R, Striano P, Traverso M, Viri M, et al
    Corrigendum to "Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation" [Brain Dev. 38(1) (2016) 128-131].
    Brain Dev. 2023 Nov 24:S0387-7604(23)00176.
    PubMed    


  34. ANUAR MA, Lee JX, Musa H, Abd Hadi D, et al
    Severe and rare neurological manifestations following COVID-19 infection in children: A Malaysian tertiary centre experience.
    Brain Dev. 2023;45:547-553.
    PubMed     Abstract available


  35. AMORE G, Cali E, Spano M, Ceravolo G, et al
    ATP6V1B2-related disorders featuring Lennox-Gastaut-syndrome: A case-based overview.
    Brain Dev. 2023;45:588-596.
    PubMed     Abstract available


    October 2023
  36. UEDA Y, Furugen A, Kobayashi M, Sato Y, et al
    Use of lacosamide for focal epilepsy in a child with kidney failure undergoing peritoneal dialysis.
    Brain Dev. 2023 Oct 30:S0387-7604(23)00156.
    PubMed     Abstract available


    August 2023
  37. SHIRAISHI H, Egawa K, Murakami K, Nakajima M, et al
    Transcutaneous auricular vagus nerve stimulation therapy in patients with cognitively preserved structural focal epilepsy: A case series report.
    Brain Dev. 2023 Aug 30:S0387-7604(23)00148.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.